Here's what to expect this week on Diagnostic Imaging.
In this week’s preview, here are some highlights of what you can expect to see coming soon:
Peer review has been widely used as a tactic for identifying diagnostic errors and opportunities for improvement. However, it has fallen short of its goal of helping radiologists learn from mistakes. Consequently, the specialty is shifting toward peer learning – a strategy that allows for anonymous critique of diagnostic oversights and gives providers guidance to avoid future errors. This week, look for an interview with Regan City from RadPartners about how facilities and institutions can implement their own peer learning models.
For additional articles on RadPartners, click here.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
Medical breakthroughs, including those with imaging technologies, are critical to bringing patients the most cutting-edge treatments possible, particularly those who live with debilitating and unmet health needs. Earlier this year, the Centers for Medicare & Medicaid Services (CMS) finalized the Medicare Coverage of Innovative Technology program, an initiative designed to close the gap between the Food & Drug Administration approval process and CMS’s approval of insurance coverage. Full implementation of the program has been delayed, however. Later this week, look for a column from Jessica Foley, Ph.D., chief science officer from the Focused Ultrasound Foundation and Patrick Hope, executive director of MITA, calling for and explaining the need for swift program implementation.
For additional thought leadership on the importance of medical innovation, click here.
Breast imaging services – mammography and digital breast tomosynthesis – are effective in detecting breast cancers, leading women to get the services they need for treatment. However, access to these studies is not even across all patient populations. Ensuring that all women have equal access requires a well designed strategy. Look for a column later this week from Christine Murray, women’s health product manager from Fujifilm Medical Systems U.S.A., Inc., about the multi-pronged approach that help increase access for all women to these life-saving services.
For other articles on breast imaging, click here.
Mammography Study Suggests DBT-Based AI May Help Reduce Disparities with Breast Cancer Screening
December 13th 2024New research suggests that AI-powered assessment of digital breast tomosynthesis (DBT) for short-term breast cancer risk may help address racial disparities with detection and shortcomings of traditional mammography in women with dense breasts.
Mammography News: FDA Grants Expanded 510(k) Clearance for AI-Powered SmartMammo Dx DBT Software
November 29th 2024Originally cleared by the FDA in 2021, the SmartMammo Dx software for digital breast tomosynthesis (DBT) can now be utilized with the Senographe Pristina mammography systems from GE HealthCare.